Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial

NCT01492504

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Alabama Liver & Digestive Specialists (Alds) Montgomery, Alabama, United States
  • Pacific Oaks Medical Group Beverly Hills, California, United States
  • Southern California Research Center Coronado, California, United States
  • Scripps Clinic La Jolla, California, United States
View all 161 locations
View Trial Details
Completed

Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection

NCT03235349

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +28 more
Locations
  • Peking University Peoples Hospit /ID# 156851 Beijing, Beijing Municipality, China
  • Guangzhou Eighth People's Hosp /ID# 156865 Guangzhou, Guangdong, China
  • Guangdong General Hospital /ID# 156827 Guangzhou, Guangdong, China
  • Nanfang Hospital of Southern Medical University /ID# 156866 Guangzhou, Guangdong, China
View all 34 locations
View Trial Details
Completed

Staged Phase I/II Hepatitis C Prophylactic Vaccine

NCT01436357

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • University of California San Francisco - Tenderloin Clinical Research Center San Francisco, California, United States
  • UCSF Community Research Center San Francisco, California, United States
  • Zuckerberg San Francisco General Hospital Unit 5B San Francisco, California, United States
  • Johns Hopkins School of Public Health - Wood Clinic Baltimore, Maryland, United States
View Trial Details
Completed

A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3

NCT01364090

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Hunter Pharmacotherapy Newcastle, New South Wales, Australia
  • Nepean Hospital Penrith, New South Wales, Australia
  • St Vincent's Hospital Sydney, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View all 17 locations
View Trial Details
Completed

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

NCT03002818

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus (HCV), +15 more
Locations
  • Kantonsspital St. Gallen Sankt Gallen, Canton of St. Gallen, Switzerland
  • Inselspital, Universitaetsklin Bern, Switzerland
  • Fondazione Epatocentro Ticino Lugano, Switzerland
  • Hopital Neuchatelois Neuchâtel, Switzerland
View Trial Details

Related conditions